Lilly deSouza Burr

Joining the AXA IM Alts team in 2023, Lilly brings to the Healthcare Private Equity investment management team experience across healthcare, corporate law, finance and investing. Having spent the previous four years as an investor at Adjuvant Capital, Lilly pulls from her experience in global health alongside all aspects of deal structuring and portfolio management.

Previously, Lilly was a senior associate in Citi’s healthcare investment banking group, advising clients across the biotech, pharma, medtech and services sectors on strategic and operational planning, M&A transactions and equity and debt financings. Prior to Citi, Lilly practiced law in the M&A group at Davis Polk & Wardwell, LLP.

Lilly also spent time before law school at the Neurosciences Clinic at the Ottawa Hospital, where she managed a clinical neurosurgery practice and focused on spinal cord injury research.

Lilly holds a JD from Georgetown University Law Center and a BS from the University of Ottawa.